Sonova AG
Sonova is a global leader in innovative hearing care solutions, including hearing aids, cochlear implants, wireless communication systems, digital solutions, and audiological care. Founded in 1947 and headquartered in Switzerland, Sonova operates through four main businesses and a portfolio of core brands, serving customers in over 100 countries. The company's mission is to create a world where everyone enjoys the delight of hearing, driven by customer-driven innovation and a broad range of solutions tailored to individual needs.
Industries
Nr. of Employees
Very Large (1000+)
Sonova AG
Laubisruetistrasse 28, 8712 Stäfa, Switzerland
Patents
Hearing device-based systems and methods for determining a heart rate value
US-12303258-B2
View DetailsHearing device-based systems and methods for determining a quality index for a cardiorespiratory measurement
US-12156742-B2
View DetailsMethod and system for streaming a multichannel audio signal to a binaural hearing system
US-12149892-B2
View Details
Hearing device-based systems and methods for determining a heart rate value
US-12303258-B2
View DetailsHearing device-based systems and methods for determining a quality index for a cardiorespiratory measurement
US-12156742-B2
View DetailsMethod and system for streaming a multichannel audio signal to a binaural hearing system
US-12149892-B2
View DetailsProducts
Hearing instruments (hearing aids)
Range of engineered hearing devices for mild to advanced hearing loss intended for clinical fitting and consumer use.
Cochlear implant systems
Implantable hearing systems designed for people with severe to profound hearing loss, including internal implant components and external processors.
Consumer audio products (headphones, hearables, soundbars)
Consumer-focused audio products incorporating speech enhancement and wireless features available under consumer-audio licensing arrangements.
Hearing instruments (hearing aids)
Range of engineered hearing devices for mild to advanced hearing loss intended for clinical fitting and consumer use.
Cochlear implant systems
Implantable hearing systems designed for people with severe to profound hearing loss, including internal implant components and external processors.
Consumer audio products (headphones, hearables, soundbars)
Consumer-focused audio products incorporating speech enhancement and wireless features available under consumer-audio licensing arrangements.
Services
Hearing tests, audiological diagnostics, personalized device fitting and ongoing clinical support delivered through a network of retail clinics and audiology professionals.
End-to-end device development, regulatory preparation and global product rollout for hearing instruments, cochlear implants and consumer audio devices.
Digital device features, mobile apps and cloud services enabling device personalization, remote adjustments and analytics.
Hearing tests, audiological diagnostics, personalized device fitting and ongoing clinical support delivered through a network of retail clinics and audiology professionals.
End-to-end device development, regulatory preparation and global product rollout for hearing instruments, cochlear implants and consumer audio devices.
Digital device features, mobile apps and cloud services enabling device personalization, remote adjustments and analytics.
Expertise Areas
- Hearing instrument design and manufacturing
- Audiological care and clinical diagnostics
- Cochlear implant system development
- Digital health and embedded audio software
Key Technologies
- AI-driven adaptive audio processing (DNN)
- Wireless audio transmission
- Rechargeable lithium‑ion battery integration
- Embedded device firmware and mobile app integration
News & Updates
Sonova announced its financial results for 2024/25, with market share gains across all four businesses and a CEO transition.
Sonova reports market share gains across all four businesses in the 2024/25 financial year.
Sonova announced its financial results for 2024/25, with market share gains across all four businesses and a CEO transition.
Sonova reports market share gains across all four businesses in the 2024/25 financial year.